Article Download
Expediting CAR T-Cell Therapy Development Using High-Throughput Technologies
In recent years, researchers have achieved a breakthrough in preventing cancer cells from evading the immune system using CAR T-cell therapy. Despite the success of CAR T-cell therapies in treating blood- and marrow-based cancers, many challenges currently limit their use in treating other types of cancers.
Read about the technological and clinical hurdles facing CAR T-cell therapies and their application to solid tumors. See how high-throughput assays provide a cost-effective route for the development of CAR-T cells, including topics on:
- Tracking CAR T-cell responses with flow cytometry
- Using ddPCR for CAR gene quality control
- Minimizing CAR T-cell therapy side effects
Download the Article
Share a little information with us to access the entire article now.
Content you'll also find interesting
Recommended Features
-
Image
Understanding Potency in Cell and Gene Therapy Development
Read about the current state of the CGT industry and challenges associated with potency assays and measuring product potency throughout the manufacturing process.
-
Image
Building and Optimizing Complex, High-Throughput Immunophenotyping Panels
Follow best practice guidelines on aspects of immunophenotyping for building, optimizing, and performing complex and high-throughput immunophenotyping panels.
-
Image
Are Costly Experimental Failures Causing a Reproducibility Crisis?
Learn about the reproducibility crisis pervading life science and the strategies to improve the success and reproducibility of your results.
